NEU neuren pharmaceuticals limited

Ann: Phase 3 trial of trofinetide in Rett syndrome commences, page-19

  1. 1,639 Posts.
    lightbulb Created with Sketch. 371
    I think one reason is a possible TO. 5 orphan drug designations, with 1 in P3 and another P2, is attractive.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.16
Change
0.620(4.94%)
Mkt cap ! $1.640B
Open High Low Value Volume
$12.96 $14.00 $12.91 $18.22M 1.337M

Buyers (Bids)

No. Vol. Price($)
6 180 $13.16
 

Sellers (Offers)

Price($) Vol. No.
$13.18 517 5
View Market Depth
Last trade - 15.54pm 26/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.